Td Private Client Wealth LLC Vaxcyte, Inc. Transaction History
Td Private Client Wealth LLC
- $3.63 Trillion
- Q1 2025
A detailed history of Td Private Client Wealth LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 18 shares of PCVX stock, worth $645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$645% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
351Shares Held
126MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$429 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$379 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$356 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$311 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$223 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.13B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...